What is Alzheimer's, how common is it – and will new drug lecanemab help patients in the UK?
A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer's disease.
Full Article
What is Alzheimer's, how common is it – and will new drug lecanemab help patients in the UK?
Sky News
0 shares
1 views
You might like
Related news coverage
New drug is 'beginning of the end' of Alzheimer's - who will it help and when will it be available?
Hull Daily Mail
Lecanemab has been shown in trials to slow the progress of early-stage Alzheimer's by 27%
-
FDA clears 1st fecal transplant treatment for gut infection
SeattlePI.com
-
This Alzheimer’s drug slowed cognitive decline in some patients. Analysts say it could become a blockbuster hit
Upworthy
-
Alzheimer's drug trial shown to slow cognitive decline in long fight against dementia
Upworthy
-
New Alzheimer's drug faces uncertain regulatory path
Upworthy
Advertisement
More coverage
What is Alzheimer's, how common is it – and will new drug Lecanemab help patients in the UK?
Sky News
A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer's disease.
-
New data shows Alzheimer's drug can slow cognitive decline
Upworthy
-
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
Upworthy
-
Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus By Reuters
Upworthy
-
A new Alzheimer’s treatment may help some patients, though researchers say more safety data is needed
Upworthy